Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies
Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies is a paper indexed in PICO Portal from OpenAlex.
How many citations does Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies have?
Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies has 194 citations in the OpenAlex counts PICO Portal stores.
When was Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies published?
Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies has 2007 year in the PICO Portal index.
What is the open-access status of Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies?
Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies has bronze oa status in the PICO Portal index.
What is the DOI of Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies?
The DOI for Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies is on the source record.
What is the PMID of Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies?
The PMID for Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies is on the source record.
What is the OpenAlex record for Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies?
The OpenAlex for Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies is on the source record.